獣医用腎疾患の市場規模、シェア、動向分析レポート：タイプ別、動物タイプ別、投与経路別、適応症別、流通チャネル別、地域別、セグメント別予測、2024年～2030年

獣医用腎疾患市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の獣医用腎疾患市場規模は2030年までに229億米ドルに達すると予測され、2024年から2030年までのCAGRは5.49％で成長すると予測されています。

腎疾患の有病率の上昇と治療としての治療食の採用が、この市場の主要な成長促進要因です。慢性腎臓病（CKD）、腎不全などの腎疾患は、動物の腎系に不可逆的な損傷を与えます。この病気には明確な治療法がないにもかかわらず、さまざまな種類の治療法によって適切に管理することで、動物の生命を向上させることができます。最も顕著な方法のひとつは、療法食による栄養管理です。

もう一つの重要な市場推進力は、獣医用腎疾患の診断と治療におけるAIの採用が増加していることです。画像診断は、病気や傷害の評価だけでなく、定期的な予防措置に不可欠なデータを提供することで、獣医学において重要な役割を果たしています。AIは、特に放射線科医が不足している地域において、非常に有益なツールであることが証明できます。より迅速で強化された診断能力などの関連する利点は、AIの採用を増加させ、それによって近い将来の市場にプラスの影響を与えると予想されます。

動物医療分野で著名なマース社は、AIを動物用診断・治療に応用する分野に既に参入しています。アンテック・ダイアグノスティックス（マース社）は2019年に最先端の診断ツールであるRenalTechを発表しました。RenalTechは人工知能（AI）を使ってペットのカルテデータを評価し、確立された臨床診断よりも最大2年先まで猫の慢性腎臓病（CKD）発症リスクを予測します。

さらに、製品ポートフォリオの拡大、M&A、統合活動などの市場力学は、この市場に成長基盤を提供すると予想されます。例えば、2023年9月、エランコ・アニマル・ヘルス社は、慢性腎臓病（CKD）の猫における非再生性貧血の治療薬として、Varenzin-CA1（molidustat経口懸濁液）の条件付き承認を米国FDAから取得しました。さらに2023年12月、ネオジェン・コーポレーションはフロリダ州ミャッカシティにあるTerraNova Equestrian Centerと提携し、診断検査製品について同施設の公式バイオセキュリティプロバイダーとなりました。

獣医用腎疾患市場レポートハイライト

• タイプ別では、治療分野が2023年に68.99%の最大収益シェアで市場をリード。これは、利用可能な治療法が豊富であることと、世界的にペットの人口が増え続けていることによります。
• 動物タイプ別では、猫セグメントが予測期間中に最も速いCAGRで成長すると予測されます。
• 投与経路に基づくと、経口セグメントは2023年に最大の収益シェアを占め、注射セグメントは予測期間に最も速いCAGRが予測されます。
• 適応症に基づくと、腎膀胱炎セグメントは2023年に29.74％の最大の収益シェアを占め、腎炎セグメントは予測期間で2番目に速いCAGRを有すると予想されます。
• 動物における様々な腎合併症の有病率の上昇、ペットフードの顕著な使用、疾患啓発イニシアチブの高まりが市場成長に寄与しています。
• 北米は、2023年の市場で最大の収益シェアを占めました。この地域全体で動物医療全般の重要性が高まっていることが、市場拡大を促進する重要な要因として認識されています。米国ペット用品協会は、2023-2024年に同国でペットを飼っている家庭は6,510万戸に上ると推定しています。さらに、動物の健康に対する飼い主の意識の高まりと、腎障害を持つ動物にケアを提供することの重要性が、北米での市場拡大に拍車をかけています。
• 2023年5月、Dechra Pharmaceuticals社は、高齢猫用の腎臓の健康をサポートする2つの製品、Porus OneとAdd Oneの販売権を発表しました。Porus Oneは、選択的吸収剤であるrenaltecを含有しており、通常であれば健康な腎臓によって除去または調節される尿毒症毒素の前駆物質を猫の腸内で吸収します。Add Oneは、高齢猫用に開発されたしっとりタイプの猫用おやつで、ポラスワンを食べるように促すために開発され、ドライフードを好む猫にも有用と言われています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 獣医用腎疾患市場：変数、動向、および範囲

• 市場系統の見通し
• 規制の枠組み
• 主要種・主要国別の推定ペット数（2018-2023）
• 米国のペット所有者の人口統計、2022年と2023年、世代別
• ペットの腎臓病の有病率
• 製品価格分析
• 消費者の好みの分析
• 獣医用腎疾患市場力学
• 獣医用腎疾患市場：ポーターのファイブフォース分析
• 獣医用腎疾患市場：PESTEL分析
• COVID-19の影響分析

第4章 タイプの推定・動向分析、2018～2030年（100万米ドル）

• タイプ別の獣医用腎疾患市場：重要なポイント
• タイプの変動分析と市場シェア、2023年と2030年
• タイプ別
• 診断
• 治療

第5章 動物タイプの推定・動向分析、2018～2030年（100万米ドル）

• 動物タイプ別の獣医用腎疾患市場：重要なポイント
• 動物タイプの変動分析と市場シェア、2023年と2030年
• 動物タイプ別
• 犬
• 猫
• 牛
• 馬
• その他

第6章 投与経路の推定・動向分析、2018～2030年（100万米ドル）

• 投与経路別の獣医用腎疾患市場：重要なポイント
• 行政経路の変動分析と市場シェア、2023年と2030年
• 投与経路別
• 経口
• 注射

第7章 適応症の推定・動向分析、2018～2030年（100万米ドル）

• 適応症別の獣医用腎疾患市場：重要なポイント
• 適応症の変動分析と市場シェア、2023年と2030年
• 適応症別
• 腎不全
• 慢性腎臓病（CKD）
• 腎膀胱炎
• 腎臓結石
• 腎炎
• その他

第8章 流通チャネルの推定・動向分析、2018～2030年（100万米ドル）

• 流通チャネル別の獣医用腎疾患市場：重要なポイント
• 流通チャネルの変動分析と市場シェア、2023年と2030年
• 流通チャネル別
• 動物病院・クリニック
• ペット専門店
• eコマース
• その他

第9章 地域の推定・動向分析、2018～2030年（100万米ドル）

• 地域の見通し
• 地域の市場シェア分析、2023年および2030年
• 地域のマーケットプレース、重要なポイント
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • デンマーク
  • ノルウェー
  • スウェーデン
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • クウェート
  • アラブ首長国連邦

第10章 競合情勢

• 参入企業の概要
• 財務実績
• サービスのベンチマーク
• 市場参入企業の分類
• 推定市況分析、2022年（ヒートマップ分析）
• 戦略マッピング
  • 拡大
  • 合併と買収
  • パートナーシップとコラボレーション
  • サービスの開始/拡張
  • その他
• 企業プロファイル
  • Mars inc.
  • Nestle Purina Petcare
  • Hills Pet Nutrition.
  • JM Smucker.
  • General Mills
  • Zoetis Inc.
  • Merck &Co. Inc.
  • Elanco.
  • Phibro Animal Health Corporation.
  • Ceva Sante Animale
  • Boehringer Ingelheim Animal Health
  • Dechra Pharmceuticals
  • VetPharma
  • Vedco Inc.
  • Mission Pharmacal Company
  • Rayne Clinical Nutrition
  • Neogen Corporation.
  • Roquette Freres
  • JP Farma
  • Richmond Vet Pharma
  • IDEXX Laboratories Inc.
  • Fujifilm Holdings Corporation
  • Carestream Health.
  • Mindray Bio-Medical Electronics Co., Ltd.

第11章 重要なポイント

List of Tables

• Table 1 Country share estimation
• Table 2 List of market players
• Table 3 North America Veterinary Renal Diseases market, by region, 2018 - 2030 (USD Million)
• Table 4 North America Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
• Table 5 North America Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
• Table 6 North America Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
• Table 7 North America Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
• Table 8 North America Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
• Table 9 US Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
• Table 10 US Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
• Table 11 US Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
• Table 12 US Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
• Table 13 US Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
• Table 14 Canada Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
• Table 15 Canada Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
• Table 16 Canada Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
• Table 17 Canada Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
• Table 18 Canada Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
• Table 19 Europe Veterinary Renal Diseases market, by region, 2017- 2030 (USD Million)
• Table 20 Europe Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
• Table 21 Europe Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
• Table 22 Europe Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
• Table 23 Europe Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
• Table 24 Europe Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
• Table 25 UK Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
• Table 26 UK Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
• Table 27 UK Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
• Table 28 UK Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
• Table 29 UK Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
• Table 30 Germany Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
• Table 31 Germany Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
• Table 32 Germany Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
• Table 33 Germany Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
• Table 34 Germany Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
• Table 35 Italy Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
• Table 36 Italy Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
• Table 37 Italy Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
• Table 38 Italy Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
• Table 39 Italy Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
• Table 40 France Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
• Table 41 France Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
• Table 42 France Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
• Table 43 France Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
• Table 44 France Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
• Table 45 Spain Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
• Table 46 Spain Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
• Table 47 Spain Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
• Table 48 Spain Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
• Table 49 Spain Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
• Table 50 Denmark Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
• Table 51 Denmark Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
• Table 52 Denmark Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million
• Table 53 Denmark Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
• Table 54 Denmark Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
• Table 55 Sweden Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
• Table 56 Sweden Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
• Table 57 Sweden Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
• Table 58 Sweden Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
• Table 59 Sweden Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
• Table 60 Norway Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
• Table 61 Norway Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
• Table 62 Norway Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
• Table 63 North America Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
• Table 64 Norway Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
• Table 65 Asia Pacific Veterinary Renal Diseases market, by region, 2018 - 2030 (USD Million)
• Table 66 Asia Pacific Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
• Table 67 Asia Pacific Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
• Table 68 Asia Pacific Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
• Table 69 Asia Pacific Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
• Table 70 Asia Pacific Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
• Table 71 Japan Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
• Table 72 Japan Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
• Table 73 Japan Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
• Table 74 Japan Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
• Table 75 Japan Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
• Table 76 China Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
• Table 77 China Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
• Table 78 China Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
• Table 79 China Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
• Table 80 China Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
• Table 81 India Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
• Table 82 India Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
• Table 83 India Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
• Table 84 India Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
• Table 85 India Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
• Table 86 Australia Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
• Table 87 Australia Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
• Table 88 Australia Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
• Table 89 North America Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
• Table 90 Australia Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
• Table 91 Thailand Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
• Table 92 Thailand Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
• Table 93 Thailand Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
• Table 94 Thailand Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
• Table 95 Thailand Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
• Table 96 South Korea Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
• Table 97 South Korea Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
• Table 98 South Korea Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
• Table 99 South Korea Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
• Table 100 South Korea Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
• Table 101 Latin America Veterinary Renal Diseases market, by region, 2018 - 2030 (USD Million)
• Table 102 Latin America Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
• Table 103 Latin America Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
• Table 104 Latin America Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
• Table 105 Latin America Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
• Table 106 Latin America Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
• Table 107 Brazil Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
• Table 108 Brazil Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
• Table 109 Brazil Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
• Table 110 Brazil Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
• Table 111 Brazil Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
• Table 112 Mexico Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
• Table 113 Mexico Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
• Table 114 Mexico Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
• Table 115 Mexico Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
• Table 116 Mexico Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
• Table 117 Argentina Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
• Table 118 Argentina Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
• Table 119 Argentina Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
• Table 120 Argentina Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
• Table 121 Argentina Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
• Table 122 MEA Veterinary Renal Diseases market, by region, 2018 - 2030 (USD Million)
• Table 123 MEA Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
• Table 124 MEA Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
• Table 125 MEA Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
• Table 126 MEA Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
• Table 127 MEA Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
• Table 128 South Africa Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
• Table 129 South Africa Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
• Table 130 South Africa Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
• Table 131 South Africa Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
• Table 132 South Africa Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
• Table 133 Saudi Arabia Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
• Table 134 Saudi Arabia Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
• Table 135 Saudi Arabia Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
• Table 136 Saudi Arabia Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
• Table 137 Saudi Arabia Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
• Table 138 UAE Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
• Table 139 UAE Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
• Table 140 UAE Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
• Table 141 UAE Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
• Table 142 UAE Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
• Table 143 Kuwait Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
• Table 144 Kuwait Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
• Table 145 Kuwait Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
• Table 146 Kuwait Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
• Table 147 Kuwait Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
• Table 148 List of secondary sources
• Table 149 List of emerging companies
• Table 150 Canine, Feline, Equine & Bovine population (in millions)

List of Figures

• Fig. 1 Veterinary Renal Diseases market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Data analysis models
• Fig. 6 Market formulation and validation
• Fig. 7 Data validating & publishing
• Fig. 8 Commodity flow analysis
• Fig. 9 Volume-price market analysis: veterinary renal diseases services market
• Fig. 10 Ancillary market analysis
• Fig. 11 Market snapshot
• Fig. 12 Segment snapshot
• Fig. 13 Segment snapshot
• Fig. 14 Competitive landscape snapshot
• Fig. 15 Parent market outlook
• Fig. 16 Ancillary market outlook
• Fig. 17 Demographics of American pet owners, based on generation, %, 2022
• Fig. 18 Demographics of American pet owners, based on generation, %, 2023
• Fig. 19 veterinary renal diseases market dynamics
• Fig. 20 veterinary renal diseases market: PORTER's analysis
• Fig. 21 veterinary renal diseases market: PESTEL analysis
• Fig. 22 veterinary renal diseases market by Type: Key takeaways
• Fig. 23 veterinary renal diseases market by Type, market share, 2023 & 2030
• Fig. 24 Diagnosis market, 2018 - 2030 (USD Million)
• Fig. 25 Treatment, 2018 - 2030 (USD Million)
• Fig. 26 Drugs market, 2018 - 2030 (USD Million)
• Fig. 27 veterinary renal diseases market by animal type: Key takeaways
• Fig. 28 veterinary renal diseases market by animal type, market share, 2023 & 2030
• Fig. 29 Canine market, 2018 - 2030 (USD Million)
• Fig. 30 Feline market, 2018 - 2030 (USD Million)
• Fig. 31 Bovine market, 2018 - 2030 (USD Million)
• Fig. 32 Equine market, 2018 - 2030 (USD Million)
• Fig. 33 Others market, 2018 - 2030 (USD Million)
• Fig. 34 veterinary renal diseases market by route of administration: Key takeaways
• Fig. 35 veterinary renal diseases market by route of administration, market share, 2023 & 2030
• Fig. 36 Oral market, 2018 - 2030 (USD Million)
• Fig. 37 Injectable market, 2018 - 2030 (USD Million)
• Fig. 38 veterinary renal diseases market by indication: Key takeaways
• Fig. 39 veterinary renal diseases market by Indication, market share, 2023 & 2030
• Fig. 40 Renal Failure market, 2018 - 2030 (USD Million)
• Fig. 41 Chronic Kidney Disease (CKD) market, 2018 - 2030 (USD Million)
• Fig. 42 Renal Cystitis market, 2018 - 2030 (USD Million)
• Fig. 43 Kidney Stones market, 2018 - 2030 (USD Million)
• Fig. 44 Nephritis market, 2018 - 2030 (USD Million)
• Fig. 45 Others market, 2018 - 2030 (USD Million)
• Fig. 46 Veterinary Renal Diseases market by Distribution channel: Key takeaways
• Fig. 47 Veterinary Renal Diseases market by distribution channel, market share, 2023 & 2030
• Fig. 48 Veterinary hospitals & clinics market, 2018 - 2030 (USD Million)
• Fig. 49 Pet Specialty Stores market, 2018 - 2030 (USD Million)
• Fig. 50 E-commerce market, 2018 - 2030 (USD Million)
• Fig. 51 Others market, 2018 - 2030 (USD Million)
• Fig. 52 veterinary renal diseases market revenue, by region, 2023 & 2030 (USD Million)
• Fig. 53 Regional market share analysis, 2023 & 2030
• Fig. 54 Regional marketplace: key takeaways
• Fig. 55 Regional marketplace: key takeaways
• Fig. 56 North America: SWOT analysis
• Fig. 57 North America veterinary renal diseases market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 58 Key country dynamics
• Fig. 59 U.S. veterinary renal diseases market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 60 Key country dynamics
• Fig. 61 Canada veterinary renal diseases market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 62 Europe: SWOT analysis
• Fig. 63 Europe veterinary renal diseases market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 64 Key country dynamics
• Fig. 65 Germany veterinary renal diseases market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 66 Key country dynamics
• Fig. 67 UK veterinary renal diseases market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 68 Key country dynamics
• Fig. 69 France veterinary renal diseases market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 70 Key country dynamics
• Fig. 71 Spain veterinary renal diseases market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 72 Key country dynamics
• Fig. 73 Italy veterinary renal diseases market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 74 Key country dynamics
• Fig. 75 Denmark veterinary renal diseases market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 76 Fih.72 Key country dynamics
• Fig. 77 Norway veterinary renal diseases market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 78 Key country dynamics
• Fig. 79 Sweden veterinary renal diseases market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 80 Asia Pacific SWOT Analysis
• Fig. 81 Asia Pacific veterinary renal diseases market, 2018 - 2030 (USD Million)
• Fig. 82 Key country dynamics
• Fig. 83 Japan veterinary renal diseases market, 2018 - 2030 (USD Million)
• Fig. 84 Key country dynamics
• Fig. 85 China veterinary renal diseases market, 2018 - 2030 (USD Million)
• Fig. 86 Key country dynamics
• Fig. 87 India veterinary renal diseases market, 2018 - 2030 (USD Million)
• Fig. 88 Key country dynamics
• Fig. 89 Australia veterinary renal diseases market, 2018 - 2030 (USD Million)
• Fig. 90 Key country dynamics
• Fig. 91 South Korea veterinary renal diseases market, 2018 - 2030 (USD Million)
• Fig. 92 Key country dynamics
• Fig. 93 Thailand veterinary renal diseases market, 2018 - 2030 (USD Million)
• Fig. 94 Latin America SWOT analysis
• Fig. 95 Latin America veterinary renal diseases market, 2018 - 2030 (USD Million)
• Fig. 96 Key country dynamics
• Fig. 97 Brazil veterinary renal diseases market, 2018 - 2030 (USD Million)
• Fig. 98 Mexico veterinary renal diseases market, 2018 - 2030 (USD Million)
• Fig. 99 Argentina veterinary renal diseases market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 100 MEA SWOT analysis
• Fig. 101 MEA veterinary renal diseases market, 2018 - 2030 (USD Million)
• Fig. 102 Key country dynamics
• Fig. 103 South Africa veterinary renal diseases market, 2018 - 2030 (USD Million)
• Fig. 104 Key country dynamics
• Fig. 105 Saudi Arabia veterinary renal diseases market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 106 Key country dynamics
• Fig. 107 UAE veterinary renal diseases market, 2018 - 2030 (USD Million)
• Fig. 108 Key country dynamics
• Fig. 109 Kuwait veterinary renal diseases market, 2018 - 2030 (USD Million)
• Fig. 110 Market participant categorization
• Fig. 111 Heat map analysis
• Fig. 112 Key strategies deployed by market players

Veterinary Renal Disease Market Growth & Trends:

The global veterinary renal disease market size is anticipated to reach USD 22.90 billion by 2030 and it is projected to grow at a CAGR of 5.49% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising prevalence of renal diseases coupled with adoption of therapeutic food as a treatment are key growth drivers for this market. Renal diseases like chronic kidney disease (CKD), renal failure, etc. cause irreversible damage to the renal system of animals. Despite no definite cure for this disease, proper management by various types of therapies can help in the betterment of animal life. One of the most prominent methods is that of nutritional management through therapeutic food.

Another crucial market propeller is the rising adoption of AI in veterinary renal disease diagnostics and treatment. Imaging plays a significant role in veterinary medicine by offering vital data for regular preventative measures as well as the assessment of disease and injury. AI can prove to be a very beneficial tool, especially in radiologist deficient geographies. Associated benefits such as faster and enhanced diagnostic capabilities is anticipated to increase adoption of AI and thereby influence positively on market in near future.

Mars Inc, which is a prominent player in the animal health space, has already stepped into the field of applying AI to veterinary diagnostics and treatment. Antech Diagnostics (Mars Inc.) introduced RenalTech, a cutting-edge diagnostic tool, in 2019. RenalTech uses artificial intelligence (AI) to evaluate pet medical record data and forecast a cat's risk of developing chronic kidney disease (CKD) up to two years ahead of an established clinical diagnosis.

Moreover, market dynamics such as product portfolio expansion, M&A, consolidation activities are further anticipated to provide growth platform to this market. For example, in September 2023, Elanco Animal Health received conditional U.S. FDA approval for Varenzin-CA1 (molidustat oral suspension), as the treatment to control non-regenerative anemia in cats with chronic kidney disease (CKD). Furthermore , in December 2023, Neogen Corporation partnered with the TerraNova Equestrian Center in Myakka City, Florida, making the company the official biosecurity provider of the facility for diagnostic testing products.

Veterinary Renal Disease Market Report Highlights:

• Based on type, the treatment segment led the market with the largest revenue share of 68.99% in 2023, due to the wide array of treatments available coupled with ever growing population of pets globally
• Based on animal type, the feline segment is expected to grow at the fastest CAGR over the forecast period
• Based on route of administration, the oral segment held the largest revenue share in 2023 and the injectable segment is expected to have the fastest CAGR over the forecast period
• Based on the indication, the renal cystitis segment held the largest revenue share of 29.74% in 2023 and nephritis segment is expected to have the second fastest CAGR over the forecast period
• Rising prevalence of a variety of renal complications in animals, prominent usage of pet food, growing disease awareness initiatives are contributing to the market growth
• North America accounted for the largest revenue share of the market in 2023. The increasing significance of animal health care in general throughout the region has been identified as a key factor propelling market expansion. The American Pet Products Association estimates that 65.1 million homes in the country have pets in 2023-2024. Moreover, growing pet owners' awareness of animal health and the significance of providing care for animals with renal disorders are fueling the market expansion in North America
• In May 2023, Dechra Pharmaceuticals announced distribution rights of two products to support kidney health in senior cats - Porus One, and Add One. Porus One contains renaltec, a selective absorber that soaks up precursors of uremia toxins in the cat's intestines that would ordinarily be removed or regulated by healthy kidneys. Add One is a moist cat treat designed for senior cats, developed to encourage them to eat Porus One, and is said to be useful for cats that prefer dry food

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market Segmentation and Scope
  • 1.1.1 Regional Scope
  • 1.1.2 Estimates And Forecast Timeline
• 1.2 Research Methodology
• 1.3 Information Procurement
  • 1.3.1 Purchased Database:
  • 1.3.2 Gvr's Internal Database
  • 1.3.3 Secondary Sources
  • 1.3.4 Primary Research
• 1.4 Information/Data Analysis
  • 1.4.1 Information Analysis
• 1.5 Market Formulation & Visualization
• 1.6 Data Validation & Publishing
• 1.7 Model Details
  • 1.7.1 Approach 1: Commodity Flow Analysis
    • 1.7.1.1 Hybrid Market Estimation Model
  • 1.7.2 Approach 2: Volume-Price Analysis (Bottom-Up)
  • 1.7.3 Approach 3: Ancillary Market Analysis
  • 1.7.4 Global Market: Cagr Calculation
• 1.8 List Of Secondary Sources

Chapter 2 Executive Summary

• 2.1 Market Snapshot
• 2.2 Segment Snapshot
• 2.3 Segment Snapshot
• 2.4 Competitive Landscape Snapshot

Chapter 3 Veterinary Renal Diseases Market Variables, Trends, & Scope

• 3.1 Market Lineage Outlook
  • 3.1.1 Parent Market Analysis
  • 3.1.2 Ancillary Market Analysis
• 3.2 Regulatory Framework
  • 3.2.1 North America
  • 3.2.2 Europe
  • 3.2.3 Asia Pacific
  • 3.2.4 Latin America
  • 3.2.5 Mea
• 3.3 Estimated Pet Population By Key Species & Key Countries (2018-2023)
• 3.4 U.S. Pet Owner Demographics, 2022 & 2023, By Generation
• 3.5 Prevalence Of Pet Renal Diseases
• 3.6 Product Price Analysis
• 3.7 Consumer Preference Analysis
• 3.8 Veterinary Renal Diseases Market Dynamics
  • 3.8.1 Market Driver Impact Analysis
    • 3.8.1.1 Rising Prevalence Of A Variety Of Renal Complications In Animals
    • 3.8.1.2 Prominent Usage Of Pet Food
    • 3.8.1.3 Growing Disease Awareness Initiatives
  • 3.8.2 Market Restraint Analysis
    • 3.8.2.1 Off-Label Use Of Drugs In Veterinary Treatment
    • 3.8.2.2 Lack Of Structured Regulations And Quality Control
• 3.9 Veterinary Renal Diseases Market: Porter's 5 Forces Analysis
  • 3.9.1 Threat Of New Entrants: Moderate
  • 3.9.2 Threat Of Substitutes: Low To Moderate
  • 3.9.3 Bargaining Power Of Buyers: Moderate To High
  • 3.9.4 Bargaining Power Of Suppliers: Low
  • 3.9.5 Competitive Rivalry: High
• 3.10 Veterinary Renal Diseases Market: Pestel Analysis
  • 3.10.1 Political & Legal
  • 3.10.2 Economic
  • 3.10.3 Social
  • 3.10.4 Technological
  • 3.10.5 Environmental
• 3.11 Covid-19 Impact Analysis
  • 3.11.1 Pre & Current Impact And Future Scenario
  • 3.11.2 Impact Of Covid-19 On Market Players

Chapter 4 Type Estimates & Trend Analysis, 2018 - 2030 (USD Million)

• 4.1 Veterinary Renal Diseases Market By Type: Key Takeaways
• 4.2 Type Movement Analysis & Market Share, 2023 & 2030
• 4.3 Veterinary Renal Diseases Market Estimates & Forecast, By Type (USD Million)
• 4.4 Diagnosis
  • 4.4.1 Diagnosis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.4.1.1 Test Kits & Consumables
    • 4.4.1.1.1 Test Kits & Consumables Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.4.1.2 Instruments
    • 4.4.1.2.1 Instruments Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 4.5 Treatment
  • 4.5.1 Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.5.1.1 Drugs
    • 4.5.1.1.1 Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.5.1.1.1.2 Nsaids
    • 4.5.1.1.1.2.1 Nsaids Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.5.1.1.1.3 Antibiotics
    • 4.5.1.1.1.3.1 Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.5.1.1.1.4 Cystine-Binding Agents
    • 4.5.1.1.1.4.1 Cystine Binding Agents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.5.1.1.1.5 Diuretics
    • 4.5.1.1.1.5.1 Diuretics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.5.1.1.1.6.1 Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.5.1.2 Therapeutic Food Supplements
    • 4.5.1.2.1 Therapeutic Food Supplements Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.5.1.3 Ringer Lactate Solution
    • 4.5.1.3.1 Ringer Lacate Solution Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 5 Animal Type Estimates & Trend Analysis, 2018 - 2030 (USD Million)

• 5.1 Veterinary Renal Diseases Market By Animal Type: Key Takeaways
• 5.2 Animal Type Movement Analysis & Market Share, 2023 & 2030
• 5.3 Veterinary Renal Diseases Market Estimates & Forecast, By Animal Type (USD Million)
• 5.4 Canine
  • 5.4.1 Canine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 5.5 Feline
  • 5.5.1 Feline Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 5.6 Bovine
  • 5.6.1 Bovine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 5.7 Equine
  • 5.7.1 Equine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 5.8 Others
  • 5.8.1 Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 6 Route Of Administration Estimates & Trend Analysis, 2018 - 2030 (USD Million)

• 6.1 Veterinary Renal Diseases Market By Indication: Key Takeaways
• 6.2. Route Of Administration Movement Analysis & Market Share, 2023 & 2030
• 6.3 Veterinary Renal Diseases Market Estimates & Forecast, By Route Of Administration (USD Million)
• 6.4 Oral
  • 6.4.1 Oral Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 6.5 Injectable
  • 6.5.1 Injectable Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7 Indication Estimates & Trend Analysis, 2018 - 2030 (USD Million)

• 7.1 Veterinary Renal Diseases Market By Indication: Key Takeaways
• 7.2. Indication Movement Analysis & Market Share, 2023 & 2030
• 7.3. Veterinary Renal Diseases Market Estimates & Forecast, By Indication (USD Million)
• 7.4. Renal Failure
  • 7.4.1 Renal Failure Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.5 Chronic Kidney Diseases (Ckd)
  • 7.5.1 Chronic Kidney Diseases (Ckd) Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.6 Renal Cystitis
  • 7.6.1 Renal Cystitis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.7 Kidney Stones
  • 7.7.1 Kidney Stones Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.8 Nephritis
  • 7.8.1 Nephritis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.9 Others
  • 7.9.1 Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8 Distribution Channel Estimates & Trend Analysis, 2018 - 2030 (USD Million)

• 8.1 Veterinary Renal Diseases Market By Distribution Channel: Key Takeaways
• 8.2 Distribution Channel Movement Analysis & Market Share, 2023 & 2030
• 8.3 Veterinary Renal Diseases Market Estimates & Forecast, By Distribution Channel (USD Million)
• 8.4 Veterinary Hospitals & Clinics
  • 8.4.1 Veterinary Hospitals & Clinics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.5 Pet Specialty Stores
  • 8.5.1 Pet Specialty Stores Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.6 E-Commerce
  • 8.6.1 E-Commerce Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.7 Others
  • 8.7.1 Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 9 Regional Estimates & Trend Analysis, 2018 - 2030 (USD Million)

• 9.1 Regional Outlook
• 9.2 Regional Market Share Analysis, 2023 & 2030
• 9.3 Regional Marketplace, Key Takeaways
• 9.4 Regional Marketplace, Key Takeaways
• 9.5 North America
  • 9.5.1 Swot Analysis:
  • 9.5.2 North America Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.3 U.S.
    • 9.5.3.1 Key Country Dynamics
    • 9.5.3.2 U.S. Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.4 Canada
    • 9.5.4.1 Key Country Dynamics
    • 9.5.4.2 Canada Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 9.6 Europe
  • 9.6.1 Swot Analysis:
  • 9.6.2 Europe Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6.3 Germany
    • 9.6.3.1 Key Country Dynamics
    • 9.6.3.2 Germany Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6.4 Uk
    • 9.6.4.1 Key Country Dynamics
    • 9.6.4.2 Uk Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6.5 France
    • 9.6.5.1 Key Country Dynamics
    • 9.6.5.2 France Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6.6 Spain
    • 9.6.6.1 Key Country Dynamics
    • 9.6.6.2 Spain Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6.7 Italy
    • 9.6.7.1 Key Country Dynamics
    • 9.6.7.2 Italy Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6.8 Denmark
    • 9.6.8.1 Key Country Dynamics
    • 9.6.8.2 Denmark Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6.9 Norway
    • 9.6.9.1 Key Country Dynamics
    • 9.6.9.2 Norway Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6.9 Sweden
    • 9.6.9.1 Key Country Dynamics
    • 9.6.9.2 Sweden Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 9.7 Asia Pacific
  • 9.7.1 Swot Analysis
  • 9.7.2 Asia Pacific Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.7.3 Japan
    • 9.7.3.1 Key Country Dynamics
    • 9.7.3.2 Japan Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.7.4 China
    • 9.7.4.1 Key Country Dynamics
    • 9.7.4.2 China Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.7.5 India
    • 9.7.5.1 Key Country Dynamics
    • 9.7.5.2 India Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.7.6 Australia
    • 9.7.6.1 Key Country Dynamics
    • 9.7.6.2 Australia Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.7.7 South Korea
    • 9.7.7.1 Key Country Dynamics
    • 9.7.7.2 South Korea Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.7.8 Thailand
    • 9.7.8.1 Key Country Dynamics
    • 9.7.8.2 Thailand Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 9.8 Latin America
  • 9.8.1 Latin America Swot Analysis
  • 9.8.2 Latin America Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.8.3 Brazil
    • 9.8.3.1 Key Country Dynamics
    • 9.8.3.2 Brazil Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.8.4 Mexico
    • 9.8.4.1 Mexico Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.8.5 Argentina
    • 9.8.5.1 Argentina Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 9.9 MEA
  • 9.9.1 MEA SWOT ANALYSIS
  • 9.9.2 MEA Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.9.3 South Africa
    • 9.9.3.1 Key Country Dynamics
    • 9.9.3.2 South Africa Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.9.4 Saudi Arabia
    • 9.9.4.1 Saudi Arabia Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.9.5 Kuwait
    • 9.9.5.1 Kuwait Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.9.6 UAE

Chapter 10 Competitive Landscape

• 10.1 Participants' Overview
• 10.2 Financial Performance
• 10.3 Service Benchmarking
• 10.4 Market Participant Categorization
• 10.5 Estimated Market Position Analysis, 2022 (Heat Map Analysis)
• 10.6 Strategy Mapping
  • 10.6.1 EXPANSION
  • 10.6.2 MERGERS & ACQUISITIONS
  • 10.6.3 PARTNERSHIPS & COLLABORATIONS
  • 10.6.4 SERVICE LAUNCHES/ EXPANSIONS
  • 10.6.5 OTHERS
• 10.7 Company Profiles
  • 10.7.1. Mars inc.
    • 10.7.1.1. Participant's overview
    • 10.7.1.2. Financial performance
    • 10.7.1.3. Product benchmarking
    • 10.7.1.4. Strategic initiatives
  • 10.7.2. Nestle Purina Petcare
    • 10.7.2.1. Participant's overview
    • 10.7.2.2. Financial performance
    • 10.7.2.3. Product benchmarking
    • 10.7.2.4. Strategic initiatives
  • 10.7.3. Hills Pet Nutrition.
    • 10.7.3.1. Participant's overview
    • 10.7.3.2. Financial performance
    • 10.7.3.3. Product benchmarking
    • 10.7.3.4. Strategic initiatives
  • 10.7.4. J M Smucker.
    • 10.7.4.1. Participant's overview
    • 10.7.4.2. Financial performance
    • 10.7.4.3. Product benchmarking
    • 10.7.4.4. Strategic initiatives
  • 10.7.5. General Mills
    • 10.7.5.1. Participant's overview
    • 10.7.5.2. Financial performance
    • 10.7.5.3. Product benchmarking
    • 10.7.5.4. Strategic initiatives
  • 10.7.6. Zoetis Inc.
    • 10.7.6.1. Participant's overview
    • 10.7.6.2. Financial performance
    • 10.7.6.3. Product benchmarking
    • 10.7.6.4. Strategic initiatives
  • 10.7.7. Merck & Co. Inc.
    • 10.7.7.1. Participant's overview
    • 10.7.7.2. Financial performance
    • 10.7.7.3. Product benchmarking
    • 10.7.7.4. Strategic initiatives
  • 10.7.8. Elanco.
    • 10.7.8.1. Participant's overview
    • 10.7.8.2. Financial performance
    • 10.7.8.3. Product benchmarking
    • 10.7.8.4. Strategic initiatives
  • 10.7.9. Phibro Animal Health Corporation.
    • 10.7.9.1. Participant's overview
    • 10.7.9.2. Financial performance
    • 10.7.9.3. Product benchmarking
    • 10.7.9.4. Strategic initiatives
  • 10.7.10. Ceva Sante Animale
    • 10.7.10.1. Participant's overview
    • 10.7.10.2. Financial performance
    • 10.7.10.3. Product benchmarking
    • 10.7.10.4. Strategic initiatives
  • 10.7.11. Boehringer Ingelheim Animal Health
    • 10.7.11.1. Participant's overview
    • 10.7.11.2. Financial performance
    • 10.7.11.3. Product benchmarking
    • 10.7.11.4. Strategic initiatives
  • 10.7.12. Dechra Pharmceuticals
    • 10.7.12.1. Participant's overview
    • 10.7.12.2. Financial performance
    • 10.7.12.3. Product benchmarking
    • 10.7.12.4. Strategic initiatives
  • 10.7.13. VetPharma
    • 10.7.13.1. Participant's overview
    • 10.7.13.2. Financial performance
    • 10.7.13.3. Product benchmarking
    • 10.7.13.4. Strategic initiatives
  • 10.7.14. Vedco Inc.
    • 10.7.14.1. Participant's overview
    • 10.7.14.2. Financial performance
    • 10.7.14.3. Product benchmarking
    • 10.7.14.4. Strategic initiatives
  • 10.7.15. Mission Pharmacal Company
    • 10.7.15.1. Participant's overview
    • 10.7.15.2. Financial performance
    • 10.7.15.3. Product benchmarking
    • 10.7.15.4. Strategic initiatives
  • 10.7.16. Rayne Clinical Nutrition
    • 10.7.16.1. Participant's overview
    • 10.7.16.2. Financial performance
    • 10.7.16.3. Product benchmarking
    • 10.7.16.4. Strategic initiatives
  • 10.7.17. Neogen Corporation.
    • 10.7.17.1. Participant's overview
    • 10.7.1.2. Financial performance
    • 10.7.17.3. Product benchmarking
    • 10.7.17.4. Strategic initiatives
  • 10.7.18. Roquette Freres
    • 10.7.18.1. Participant's overview
    • 10.7.18.2. Financial performance
    • 10.7.18.3. Product benchmarking
    • 10.7.18.4. Strategic initiatives
  • 10.7.19. JP Farma
    • 10.7.19.1. Participant's overview
    • 10.7.19.2. Financial performance
    • 10.7.19.3. Product benchmarking
    • 10.7.19.4. Strategic initiatives
  • 10.7.20. Richmond Vet Pharma
    • 10.7.20.1. Participant's overview
    • 10.7.20.2. Financial performance
    • 10.7.20.3. Product benchmarking
    • 10.7.20.4. Strategic initiatives
  • 10.7.21. IDEXX Laboratories Inc.
    • 10.7.21.1. Participant's overview
    • 10.7.21.2. Financial performance
    • 10.7.21.3. Product benchmarking
    • 10.7.21.4. Strategic initiatives
  • 10.7.22. Fujifilm Holdings Corporation
    • 10.7.22.1. Participant's overview
    • 10.7.22.2. Financial performance
    • 10.7.22.3. Product benchmarking
    • 10.7.22.4. Strategic initiatives
  • 10.7.23. Carestream Health.
    • 10.7.23.1. Participant's overview
    • 10.7.23.2. Financial performance
    • 10.7.23.3. Product benchmarking
    • 10.7.23.4. Strategic initiatives
  • 10.7.24. Mindray Bio-Medical Electronics Co., Ltd.
    • 10.7.24.1. Participant's overview
    • 10.7.24.2. Financial performance
    • 10.7.24.3. Product benchmarking
    • 10.7.24.4. Strategic initiatives

Chapter 11 Key Takeaways